Objective The Friedewald equation has been used as the standard formula for the estimation of very lowdensity lipoprotein cholesterol (VLDL-C) to calculate the serum levels of low-density lipoprotein cholesterol (LDL-C). However, the usefulness of this formula in non-Caucasians has been challenged in recent years. The aim of this study was to assess the validity of the conventional and modified Friedewald equation in an ethnic Chinese adult population. Methods We prospectively recruited 938 subjects from the Lipid Clinic of the National Taiwan 
Introduction
Hyperlipidemia is one of the major risk factors of cardiovascular disease. The Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Treatment Panel III (ATP III) has provided evidence-based recommendations on the management of high blood cholesterol and related disorders (1) . Low-density lipoprotein cholesterol (LDL-C) was recommended as the primary target of lipid-lowering therapy. Lowering the LDL-C levels has been recognized to reduce the risk of coronary heart disease (CHD) events and mortality in primary and secondary prevention trials (2) . Therefore, LDL-C may also be used for monitoring the effects of diet control and drug treatment. According to the ATP III algorithm, the patients are categorized into 3 risk categories. Those with CHD, or CHD risk equivalents, are classified as high risk. The goal for LDL-C lowering therapy in high-risk patients is to achieve LDL-C levels <100 mg/dL (2.59 mmol/L) (1) . Therefore, accurate and precise determinations of the patient's serum or plasma levels of LDL-C are necessary to appropriately identify the individuals with hypercholesterolemia and to monitor their response to pharmacological therapy.
The measurements of LDL-C show considerable variation in the particle size and composition, thereby making a direct and correct measurement of LDL-C difficult (3) . Ultracentrifugation is the reference method for the LDL-C measurement. However, ultracentrifugation is unavailable in most clinical laboratories and the procedure is expensive, timeconsuming, and technically demanding. A direct homogeneous LDL-C assay has become available in recent years; however, the methodology has not yet been standardized and requires additional measurements for validation, resulting in increased costs and labor. Hence, for the economic and practical reasons outlined, LDL-C is estimated using the Friedewald formula [LDL = (total cholesterol (T-CHO)) -high-density lipoprotein (HDL) -triglyceride (TG)/5] in specimens obtained from fasting subjects with TG levels <400 mg/dL (4.52 mmol/L) in most routine clinical laboratories (4) . This calculation method, proposed by Friedewald et al., assumes the TG/very low-density lipoprotein cholesterol (VLDL-C) ratio is 5. This equation is not applicable to plasma samples containing chylomicrons (4); therefore, the calculation method is not without limitations. In the case of dysbetalipoproteinemia (Type Ill hyperlipoproteinemia), which is characterized by a substantial cholesterol enrichment in VLDL-C, VLDL-C is underestimated and hence LDL-C is overestimated (4 (7) . This is contrary to the findings of Rubiés-Prat et al. who reported that LDL-C was overestimated in 39% of diabetic patients and underestimated in 13% of diabetic patients by the Friedewald equation when compared with an analysis by beta-quantification (8) . In summary, there are discrepancies between countries and ethnic groups when applying the Friedewald equation. Conversely, the calculated LDL-C is based on the measurements of total cholesterol, TG, and HDL cholesterol (HDL-C). The measurement of each is associated with a small, but finite error. The calculation of LDL-C includes the sum of all of these. In other words, even if total cholesterol, TG, and HDL-C are accurately measured, the cumulative error can affect the accuracy of the calculated LDL-C. Although an estimation of LDL-C by the Friedewald equation is universally accepted, there are many flaws with the calculated LDL-C method and a modified equation optimized for people of Chinese descent is still lacking.
Aim
To assess the validity of the conventional and modified Friedewald equations in ethnic Chinese adults, we analyzed the lipid profiles of 938 serum samples. In addition, we investigated the best appropriate constant value of the Friedewald equation in different subgroups, according to the subjects' characteristics, and established a modified equation for the estimation of the LDL-C concentration in ethnic Chinese people living in Taiwan. This study also used the calculated levels of HDL-C and LDL-C by the agarose gel electrophoresis method (Sebia, Evry Cedex, France) to validate the direct measurement of the HDL-C and LDL-C levels by a homogeneous enzymatic method with reagent kits (Denka Seiken, Tokyo, Japan).
Materials and Methods

Patients
From 2009 to 2011, 938 subjects from the Lipid Clinic of the National Taiwan University Hospital were prospectively enrolled in this study (646 men and 292 women, aged from 19 to 70 years old). The patients with secondary hyperlipidemia, such as hypothyroid disease, nephrotic syndrome, chronic kidney disease with creatinine levels ! 3, obstructive liver diseases, and malignant diseases, and those who were pregnant or taking drugs known to influence lipid metabolism were excluded. Additionally, all participants had to have no previous history of receiving lipid-lowering therapy or had to discontinue using lipid-lowering agents for at least one month before being recruited. All subjects with diabetes mellitus (DM) or histories of receiving hypertension medication were noted for further investigation. All the participants fasted for 12-14 hours and venous blood samples were collected in the morning for the measurement of serum lipid profiles. Informed consent was obtained from each patient. This study was approved by the institutional review board at the National Taiwan University Hospital.
Lipids, lipoprotein and OGTT measurements
The concentrations of lipids, including cholesterol, TG, HDL-C, and LDL-C, were analyzed using a homogeneous enzymatic method [coefficient of variation (CV) of 2%] with reagent kits. The analyses were conducted using a Toshiba FR-200 automatic chemistry analyzer (Toshiba, Tokyo, Japan). The serum T-CHO and TG were measured by automated enzymatic methods on the same analyzer with a CV of 3%. The calculated LDL-C concentrations were estimated using the modified Friedewald formula, i.e., estimated LDL-C = T-CHO -(TG/Y) -HDL-C, where Y is the constant value. To minimize calculation variations (3), we determined the lipid profiles using reagents from the same manu-facturer (Denka Seiken).
The VLDL-C concentrations were determined using the agarose gel electrophoresis method (Sebia). The levels of total cholesterol were initially measured by a commercial kit (Denka Seiken), then the VLDL-C levels were determined by the electrophoresis method to obtain the T-CHO percentage. This electrophoresis method can separate and measure the major lipoprotein components found in the serum, including chylomicrons, beta lipoproteins or LDL-C, pre-beta lipoproteins or VLDL-C, and alpha lipoproteins or HDL-C. The analysis is performed by electrophoresis on pH 7.5 buffered agarose gels. The separated lipoproteins are stained with a lipid-specific Sudan black stain. This quantitative method is in good accordance with the reference ultracentrifugation results and has been found to be reliable for clinical use by previous studies (9, 10) .
After taking the fasting blood sample, all subjects underwent an oral glucose tolerance test (OGTT) with 75 g of glucose loading, in accordance with the World Health Organization standards (11) . Then, venous blood samples were taken every 30 minutes until two hours following the OGTT, and the results were classified according to the American Diabetes Association criteria: those who have <140 mg/dL (7.78 mmol/L) glucose are classified as normal; 140-199 mg/dL (7.78-11.06 mmol/L) have impaired glucose tolerance (IGT); and those with >200 mg/dL (11.11 mmol/ L) are diabetic based on the results of the 2-hour blood glucose levels (12, 13) . The plasma glucose concentration was determined using reagent kits with the hexokinase method and analyzed on a Toshiba FR-120 automatic chemistry analyzer (Toshiba). The CV for plasma glucose is under 3%.
Based on the ATP III risk classification (2), all subjects were classified into one of five groups according to their TG concentrations [<100 mg/dL (1.13 mmol/L), n=211; 100-149 mg/dL (1.13-1.68 mmol/L), n=240; 150-199 mg/dL (1.68-2.25 mmol/L), n=138; 200-399 mg/dL (2.26-4.50 mmol/L), n=235; and ! 400 mg/dL (4.52 mmol/L), n=129]. In addition, all patients were also classified into one of three subgroups according to the cholesterol levels, ! 240 mg/dL (! 6.21 mmol/L), 200-239 mg/dL (5.17-6.21 mmol/L), and <200 mg/dL (<5.17 mmol/L), in order to explore the best constant value to use in the modified Friedewald equation. In this study, the validation of the Friedewald formula was conducted using an available commercial kit to obtain the ratio of TG/(CHO -HDL-C -LDL-C) or TG/VLDL-C.
Cardiovascular risk factors
Blood pressure (BP) measurements were performed using a mercury sphygmomanometer. Two measurements were taken after 5 minutes of rest in the sitting position. Hypertension was defined as a history of hypertension or systolic BP ! 140 mmHg or diastolic BP ! 90 mmHg; prehypertension was defined as systolic BP between 120 and 139 mmHg or diastolic BP between 80 and 89 mmHg; and normal BP was defined as systolic BP<120 mmHg and diastolic BP<80 mmHg (14) . The body mass index (BMI) was calculated as the subject's body weight in kilograms over body height in meters squared. The BMI subgroups were classified in 3 groups based on the guidelines from the Taiwan Department of Health: <24 kg/m 2 (normal), 24-27 kg/ m 2 (overweight) and ! 27 kg/m 2 (obese) (15, 16) . We arbitrarily divided all participants into 2 subgroups, ! 50 and <50 years of age, according to the mean age of all the subjects in this study (17) . The smoking history and alcohol use were obtained for each subject from a self-reported structured questionnaire. In this study, drinking two or more alcoholic drinks per week was defined as habitual drinking.
Statistical analyses
Continuous variables were expressed as the mean ± SD and categorical data were expressed as percentages. Initially, to estimate the real value of the constant by the direct VLDL-C measurements, we calculated the constant value stratified by the cardiovascular risk factors, particularly gender, TG levels, and the OGTT diagnosis. We also used the results of LDL-C from cholesterol electrophoresis to validate the measured HDL-C and LDL-C concentrations from the direct methods by commercial kits. We then estimated the constant values by the direct LDL-C measurements stratified by the cardiovascular risk factors to propose the modified equation for calculating LDL-C. At this stage in the analysis, we excluded the subjects with TG levels ! 4.52 mmol/L (400 mg/dL). Many cardiovascular risk factors are associated with the Y constant, thus we propose a multiple linear regression model to obtain the solution where the Y value is the constant value for the estimation of the LDL-C value: Y = a + b1X1 + b2X2 + b3X3 + b4X4 + b5X5 + b6X6 + b7X7, X1 = Age; X2 = Gender (men =1, women =0); X3= TG group X4= cholesterol group; X5= fasting glucose group; X6= hypertension group; X7= BMI group.
To establish the best estimated constant in the ethnic Chinese adult population, the stepwise regression models were used. Stepwise procedures by forward selection or backward elimination were applied for the multiple regression analyses to identify which factors were important for predicting the best constant Y value. The result of forward selection was a stepwise selection procedure. All analyses were performed using the SAS 9.1 software package (SAS Institute, Cary, USA). Statistical significance was considered to exist at p< 0.05. Table 1 summarizes the characteristics of the study population. No significant difference between gender groups was found with respect to BP, glucose, TG, LDL-C, and VLDL-C levels, or percentage with DM. The women tended to be older than the men. In addition, the women had higher cholesterol and HDL-C levels than the men. Conversely, only 2.6% and 4% of men and women, respectively, were receiving treatment with DM medication. Furthermore, approxi- mately 7% of all the participants were receiving treatment with hypertension medication. Thus, the possible influence on the lipid levels by DM or hypertension medication may be minimal and could be overlooked.
Results
In the present study, we used the direct VLDL-C measurements to estimate the constant stratified by the cardiovascular characteristics (Table 2 ). The constant was approximately 4.1 in all of the participants. The corresponding values in the men and women were 4.07 and 4.19, respectively. The subgroup analyses of the TG groups showed the estimated constant value was 6.17 when the TG levels were ! 400 mg/dL (4.52 mmol/L), whereas the constant value was 3.65, 3.26, 3.54, and 4.54 in the TG groups ! 200 mg/dL (2.26 mmol/L) and <400 mg/dL (4.52 mmol/L), TG groups ! 150 mg/dL (1.69 mmol/L) and <200 mg/dL (2.26 mmol/ L), TG groups ! 100 mg/dL (1.13 mmol/L) and <150 mg/dL (1.69 mmol/L), and TG groups <100 mg/dL (1.13 mmol/L), respectively. When the diabetes status was considered, by combining the patients previously diagnosed with diabetes and those diagnosed with diabetes by the OGTT, the constant value was 4.23 and the corresponding values for IGT and normal glucose tolerance were 3.95 and 4.08, respectively. In summary, the constant was found to vary among different subgroups of cardiovascular characteristics. For the practical utility, we thus estimated the constant value by the direct LDL-C measurements stratified by cardiovascular characteristics (Table 3 ). In this analysis step, all subjects and subgroups with TG levels ! 400 mg/dL were excluded to comply with the exclusion criteria of the Friedewald equation. The results showed that the estimated constant was approximately 5.73 in all of the subjects. A gender difference in this constant value was also noted (men: 6.19; women: 4.73). The constant values in those aged ! 50 or <50 years old were 5.12 and 6.22, respectively. The subgroup analyses showed that the constant value was 6.46, 6.63, 5.61 and 4.45 in the TG groups ! 200 mg/dL and <400 mg/dL, TG groups ! 150 mg/dL and <200 mg/dL, TG groups ! 100 mg/dL and <150 mg/dL, and TG groups <100 mg/dL, respectively. The subgroup analyses for the estimated constant values stratified by the cardiovascular risk factors were significantly different among men, the patients >50 years of age, cholesterol and the BMI groups. In contrast, there were no significant differences among the fasting glucose or hy- The multivariate linear regression models identified the individual contribution of the constant values by different characteristics (Table 4) . Thus, the summation of the constant value can be considered by statistical significant characteristics in each individual. The forward selection, backward elimination and stepwise procedure identified the best and simplest model to calculate the constant value was by considering age, gender, TG levels, cholesterol levels, hypertension status and the BMI simultaneously. Subsequently, we estimated an appropriate best constant value for each in- In addition, we validated a commercial ELISA kit for the direct measurement of HDL-C and LDL-C (Denka Seiken). 
Discussion
A number of interesting findings emerged from this study. First, according to the direct measurement of the LDL-C levels, we are the first to propose a modified Friedewald equation that calculates a total solution for the constant Y value by constructing a prediction model through forward selection, backward elimination, and stepwise multiple linear regression analyses, after controlling for other confounding variables. This investigation also highlighted the significant variations across various cardiovascular characteristics, which may significantly bias the application of the traditional Friedewald equation. The accuracy of the Friedewald formula depends on the assumption that the serum TG concentrations are highly correlated with the VLDL-C concen-trations (18) . However, abnormal lipoprotein compositions have been reported, including cholesterol-enriched VLDL-C due to the accumulation of remnants and TG enrichment of LDL-C and HDL-C, resulting in an inaccuracy of estimating LDL-C. This has previously been recognized for specific patient groups, such as those with diabetes, renal and liver disease (6, 7, 18, 19) . The particles found in these patients may be a heterogeneous mixture of chylomicron remnants, VLDL-C, and VLDL remnants. In the present study, we applied the direct VLDL-C and LDL-C measurements, respectively, to estimate the constant values stratified by cardiovascular characteristics and found that the constant value varies for all the participants and other cardiovascular characteristics. In contrast to previous studies, we did not provide a single constant value. However, we recommend an equation that takes into account the subject's age, gender, and cholesterol, TG levels, and BMI simultaneously. This equation is rational and clinically applicable, not only because it is based on a total solution of the multivariate models closely linked to individual cardiovascular characteristics, but also because it is simple for clinical application as these factors are easily obtainable from all patients. In addition, this study also successfully validates the clinical usefulness of the application of a currently available commercial kit for the direct measurement of HDL-C and LDL-C in the ethnic Chinese adult population.
We used the direct LDL-C levels instead of the direct VLDL-C measurement to propose the modified Friedewald equation in the present study. Although the direct VLDL-C measurements by electrophoresis could detect variant lipoprotein and showed a good correlation with ultracentrifugation (20, 21) , previous studies have suggested that electrophoretic methods may not achieve acceptable precision (18, 22) . Due to the demand for laboratory automation and the impracticality of electrophoresis in the clinical laboratory, the alternative method for most clinical practices adopts the direct LDL-C assay (23) . Since there is no reliable method to determine the "correct" LDL-C levels, based on the NCEP recommendations for the measurement of LDL-C, the total error must be less than 12% (24, 25) . The direct LDL-C measurement applied in this study meet the criteria for analytical performance. Furthermore, the adjusted R-squared of this validation study for LDL-C and HDL-C was approximately 0.8 for both values, indicating the feasible application of this direct method from the ELISA kit in clinical practice.
The findings of this study are also consistent with those of previous studies which suggested that the Friedewald equation is significantly influenced by the subject's TG levels and that the application of this modified equation should exclude TG levels greater than 400 mg/dL (4.52 mmol/ L) (26, 27) .
However, in many laboratories, the use of the calculated method is for economical reasons and health insurance finance approaches to reduce costs. In the present study, different VLDL-C results were determined directly by electrophoresis and also calculated by an equation (T-CHO-HDLC-LDLC), using homogeneous LDL-C and HDL-C assays. This discrepancy indicates that the direct LDL-C measurement or the direct VLDL-C measurement was flawed. The use of the homogeneous LDL-C and HDL-C measurement as a reference method is appropriate, given the known inaccuracies of these methods (9, 10) . The performance of directly measured VLDL-C by electrophoresis is reliable, however, the technology-demand and the cost of this method is relative high (10, 28) . In the present study, we also discovered a more suitable constant Y value of 5.7 for ethnic Chinese people by a simplified equation for those who cannot adopt the modified equation we provided (instead of the conventional Friedewald constant of 5). Furthermore, it should be noted that the patients should adhere to a 12 to 14-hour fast, in order to decrease the inaccuracy of the TG determination.
There are some limitations associated with this study. In this investigation, we only examined one of many direct measurement methods and did not compare the results with the reference method (the BQ method). However, the homogenous assay kit used to measure LDL-C in this study is certified by a previous study (26) ; they reported the total error of this kit met the NCEP total allowable error goal and was suitable for routine use.
In conclusion, this investigation identified the best appropriate modified Friedewald equation using a multivariate analysis and provided a simple equation to estimate an individual's constant Y value, instead of simply using a value of 5 for all scenarios. Due to the expense of the direct assay and the lack of availability of ultracentrifugation, this method may provide an acceptable total solution to estimate LDL-C. Our findings may contribute and broaden the usage of the modified Friedewald formula in the LDL-C estimation, particularly for hyperlipidemia in ethnic Chinese adults.
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